Trademark: 87350060
Status Date
Tuesday, December 18, 2018
Registration Number
5630340
Registration Date
Tuesday, December 18, 2018
Filing Date
Sunday, February 26, 2017
Published for Opposition
Tuesday, October 2, 2018
5 Diagnostic biomarker reagents for medical purposes; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, autoimmune disease; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, cancer; Diagnostic preparations for medical and veterinary use; Diagnostic preparations for medical or veterinary purposes; Diagnostic preparations for medical purposes; Diagnostic preparations for medical purposes for detecting the presence of malignant, inflammatory and autoimmune disorders and conditions and tissue trauma in humans; Diagnostic reagents for medicinal use; Medical diagnostic reagents; Medical diagnostic reagents and assays for testing of body fluids; all of the foregoing for use in connection with genomic molecular diagnostic testing
1 Diagnostic preparations for scientific or research use; Diagnostic preparations for clinical or medical laboratory use; Diagnostic preparations for scientific or research use; Diagnostic preparations for scientific or research use other than for medical use; Diagnostic preparations for scientific use; Diagnostic preparations other than for medical or veterinary purposes; Diagnostic preparations used in science; Diagnostic preparations, other than for medical or veterinary purposes; Diagnostic reagents and preparations, except for medical or veterinary use; Diagnostic reagents for clinical or medical laboratory use; Diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; Diagnostic reagents for scientific or research use; Diagnostic reagents for scientific use; all of the foregoing for use in connection with genomic molecular diagnostic testing
44 Medical diagnostic testing, monitoring and reporting services; Medical testing for diagnostic or treatment purposes in the field of biodosimetry; Medical testing for diagnostic or treatment purposes in the field of cancer; Medical testing for diagnostic or treatment purposes in the field of autoimmune disease; all of the foregoing for use in connection with genomic molecular diagnostic testing
10 Blood collection kit comprised of blood collection bag, holder for medical sample tubes and vials, and medical sample tubes and vials; Blood testing apparatus, namely, blood collecting tubes; Diagnostic kits consisting primarily of probes, buffers and reagents for use in microbial testing; Medical specimen collection devices in the nature of fingerstick device for the collection of blood; Medical specimen collection devices in the nature of evacuated tube for the collection of blood; all of the foregoing for use in connection with genomic molecular diagnostic testing
In the statement, line 1, "DxTerity Diagnostics, Inc." should be deleted and DxTerity Diagnostics Incorporated, should be inserted.
DX TERITY
Dec 18, 2023
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Oct 27, 2021
Automatic Update Of Assignment Of Ownership
Oct 13, 2021
Correction Under Section 7 ¿ Processed
Oct 12, 2021
Teas Response To Office Action-Post Reg Received
Oct 12, 2021
Post Registration Action Mailed - Sec. 7
Oct 12, 2021
Assigned To Paralegal
May 25, 2021
Teas Section 7 Request Received
Dec 18, 2018
Registered-Principal Register
Oct 2, 2018
Official Gazette Publication Confirmation E-Mailed
Oct 2, 2018
Published For Opposition
Sep 12, 2018
Notification Of Notice Of Publication E-Mailed
Aug 30, 2018
Approved For Pub - Principal Register
Aug 25, 2018
Teas/Email Correspondence Entered
Aug 24, 2018
Correspondence Received In Law Office
Aug 24, 2018
Teas Response To Office Action Received
Jun 7, 2018
Notification Of Non-Final Action E-Mailed
Jun 7, 2018
Non-Final Action E-Mailed
Jun 7, 2018
Non-Final Action Written
May 18, 2018
Suspension Checked ¿ To Attorney For Action
Nov 7, 2017
Notification Of Letter Of Suspension E-Mailed
Nov 7, 2017
Letter Of Suspension E-Mailed
Nov 7, 2017
Suspension Letter Written
Oct 20, 2017
Teas/Email Correspondence Entered
Oct 20, 2017
Correspondence Received In Law Office
Oct 18, 2017
Teas Response To Suspension Inquiry Received
Oct 18, 2017
Notification Of Letter Of Suspension E-Mailed
Oct 18, 2017
Letter Of Suspension E-Mailed
Oct 18, 2017
Suspension Letter Written
Oct 2, 2017
Teas/Email Correspondence Entered
Oct 2, 2017
Correspondence Received In Law Office
Sep 27, 2017
Assigned To Lie
Sep 20, 2017
Teas Response To Office Action Received
May 22, 2017
Notification Of Priority Action E-Mailed
May 22, 2017
Priority Action E-Mailed
May 22, 2017
Priority Action Written
May 22, 2017
Assigned To Examiner
Mar 7, 2017
Notice Of Pseudo Mark E-Mailed
Mar 6, 2017
New Application Office Supplied Data Entered
Mar 1, 2017
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
